Skip to main navigation
Skip to search
Skip to main content
Northwestern Scholars Home
Help & FAQ
Home
Experts
Organizations
Research Output
Grants
Core Facilities
Datasets
Search by expertise, name or affiliation
Predisposition to and late onset of upper airway obstruction following angiotensin-converting enzyme inhibitor therapy
M. Jain
, L. Armstrong, J. Hall
*
*
Corresponding author for this work
Medicine, Pulmonary Division
Research output
:
Contribution to journal
›
Article
›
peer-review
56
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Predisposition to and late onset of upper airway obstruction following angiotensin-converting enzyme inhibitor therapy'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine and Dentistry
ACE Inhibitor
100%
Angioedema
75%
Complication
50%
Upper Respiratory Tract Obstruction
50%
Patient
50%
Face
50%
Enalapril
25%
Drug Therapy
25%
Combination Therapy
25%
Lisinopril
25%
Injury
25%
Symptom
25%
Disease Predisposition
25%
Neck Surgery
25%
Neck
25%
Clinician
25%
Pharmacology, Toxicology and Pharmaceutical Science
Dipeptidyl Carboxypeptidase Inhibitor
100%
Angioneurotic Edema
75%
Complication
50%
Upper Respiratory Tract Obstruction
50%
Enalapril
25%
Lisinopril
25%
Disease Predisposition
25%
Injury
25%
Symptom
25%
INIS
enzyme inhibitors
100%
angiotensin
100%
patients
50%
surgery
25%
therapy
25%
risks
25%
administration
25%
symptoms
25%
trauma
25%